Drugs / prednisolon
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials · 1 missed | ||||||
| Phase 4 | NCT02083991 | Jan 2013 → Jan 2017 | diabetes mellitus | Vastra Gotaland Region | Completed | No outcome recorded |
| Phase 4 | NCT00724022 | Jun 2008 → Jul 2014 | disease related to solid organ transplantation | University Hospital Freiburg | Completed | Missed primary |
| Phase 4 | NCT00265772 | Nov 2005 → Apr 2008 | Crohn disease | Necker-Enfants Malades Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00359658 | Nov 2004 → Jun 2008 | — | Hannover Medical School | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 3 | NCT01288131 Comparator | Jan 2009 → Jan 2012 | pure red-cell aplasia | Chulalongkorn University | Terminated | No outcome recorded |
| Phase 4 | NCT01880307 Comparator | Jan 2013 → Dec 2014 | Crohn disease | Erasmus Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT00552526 Comparator | Nov 2007 → Jan 2011 | epilepsy | Oslo University Hospital | Unknown | No outcome recorded |
| — | NCT03601611 Background | Jan 2019 → Jan 2020 | arthritic joint disease, cancer, colitis | Herlev Hospital | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | prednisolon | “Drugs from ACT groups N03A, N05BA, N05CD, H02A or S01EC will be used including prednisolon,levetiracetam, valproate, carbamazepine, oxcarbazepine, topiramate, felbamate,...” NCT00552526 ↗7“Cyclophosphamide 100 mg QD combine with prednisolon 1.0 mg/kg/day” NCT01288131 ↗ “Prednisolon will be given in case of worsening of symptoms” NCT03601611 ↗ |
| Route | Oral | “oral prednisolone 1 mg/kg” NCT01880307 ↗ |